Andreas Halvorsen - Viking Global Investors
Holding/activity history for 4d Molecular Therapeutics In (FDMT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.24 | SEC | ||
| 2024 Q2 | 2,934,914 | 0.24 | $20.99 | $61,603,845 | SEC | ||
| 2024 Q1 | 2,934,914 | 0.35 | Reduce 38.70% | 0.14 | $31.86 | $93,506,360 | SEC |
| 2023 Q4 | 4,787,914 | 0.36 | $20.26 | $97,003,138 | SEC | ||
| 2023 Q3 | 4,787,914 | 0.25 | $12.73 | $60,950,145 | SEC | ||
| 2023 Q2 | 4,787,914 | 0.36 | Add 21.59% | 0.06 | $18.07 | $86,517,606 | SEC |
| 2023 Q1 | 3,937,914 | 0.32 | $17.19 | $67,692,742 | SEC | ||
| 2022 Q4 | 3,937,914 | 0.44 | $22.21 | $87,461,070 | SEC | ||
| 2022 Q3 | 3,937,914 | 0.15 | $8.04 | $31,661,000 | SEC | ||
| 2022 Q2 | 3,937,914 | 0.13 | $6.98 | $27,487,000 | SEC | ||
| 2022 Q1 | 3,937,914 | 0.24 | $15.12 | $59,541,000 | SEC | ||
| 2021 Q4 | 3,937,914 | 0.25 | $21.94 | $86,398,000 | SEC | ||
| 2021 Q3 | 3,937,914 | 0.29 | $26.97 | $106,206,000 | SEC | ||
| 2021 Q2 | 3,937,914 | 0.29 | $24.08 | $94,825,000 | SEC | ||
| 2021 Q1 | 3,937,914 | 0.51 | $43.38 | $170,827,000 | SEC | ||
| 2020 Q4 | 3,937,914 | 0.45 | Buy | 0.45 | $41.45 | $163,227,000 | SEC |